sebi guidelines for ipos

Upload: lalit-patil

Post on 05-Apr-2018

239 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/31/2019 SEBI Guidelines for IPOs

    1/31

    SEBI Guidelines for IPOs

    ,

    , , ....

    ,....

    ,

    ............

    1. IPOs of small companies

    Public issue of less than five crores has to be through OTCEI and separate guidelines

    apply for floating and

    listing of these issues.

    (Public Offer By Small Unlisted Companies)

    2. Size of the Public Issue

    Issue of shares to general public cannot be less than 25% of the total issue, incase of

    information technology,

    media and telecommunication sectors this stipulation is reduced subject to the conditions

    that:

    Offer to the public is not less than 10% of the securities issued.

  • 7/31/2019 SEBI Guidelines for IPOs

    2/31

    A minimum number of 20 lakh securities is offered to the public and

    Size of the net offer to the public is not less than Rs. 30 crores.

    3. Promoter Contribution

    Promoters should bring in their contribution including premium fully before the issue

    Minimum Promoters contribution is 20-25% of the public issue.

    Minimum Lock in period for promoters contribution is five years

  • 7/31/2019 SEBI Guidelines for IPOs

    3/31

    Minimum lock in period for firm allotments is three years.

    4. Collection centers for receiving applications

    There should be at least 30 mandatory collection centers, which should include

    invariably the places where stock exchanges have been established.

    For issues not exceeding Rs.10 crores (including premium, if any), the collection

    centres shall be situated at:-

    o the four metropolitan centres viz. Bombay, Delhi, Calcutta, Madras; and

    o at all such centres where stock exchanges are located in the region in which the

    registered office of

    the company is situated.

    5. Regarding allotment of shares

    Net Offer to the General Public has to be at least 25% of the Total Issue Size for

    listing on a Stock exchange.

  • 7/31/2019 SEBI Guidelines for IPOs

    4/31

    It is mandatory for a company to get its shares listed at the regional stock exchange

    where the registered office of the issuer is located.

    In an Issue of more than Rs. 25 crores the issuer is allowed to place the whole issue

    by book-building

    Minimum of 50% of the Net offer to the Public has to be reserved for Investors

    applying for less than 1000 shares.

    There should be atleast 5 investors for every 1 lakh of equity offered (not applicable

    to infrastructure companies).

    Quoting of Permanent Account Number or GIR No. in application for allotment of

    securities is compulsory where monetary value of Investment is Rs.50,000/- or

  • 7/31/2019 SEBI Guidelines for IPOs

    5/31

    above.

    Indian development financial institutions and Mutual Fund can be allotted securities

    upto 75% of the Issue Amount.

    A Venture Capital Fund shall not be entitled to get its securities listed on any stock

    exchange till the expiry of 3 years from the date of issuance of securities.

    Allotment to categories of FIIs and NRIs/OCBs is upto a maximum of 24%, which can

    be further extended to 30% by an application to the RBI - supported by a resolution

    passed in the General Meeting.

    6. Timeframes for the Issue and Post- Issue formalities

    The minimum period for which a public issue has to be kept open is 3 working days

    and the maximum for which it can be kept open is 10 working days. The minimum

    period for a rights issue is 15 working days and the maximum is 60 working days.

  • 7/31/2019 SEBI Guidelines for IPOs

    6/31

    A public issue is effected if the issue is able to procure 90% of the Total issue size

    within 60 days from the date of earliest closure of the Public Issue. In case of over-

    subscription the company may have the right to retain the excess application money

    and allot shares more than the proposed issue, which is referred to as the green-

    shoe option.

    A rights issue has to procure 90% subscription in 60 days of the opening of the

    issue.

    Allotment has to be made within 30 days of the closure of the Public Issue and 42

    days in case of a Rights issue.

    All the listing formalities for a public Issue has to be completed within 70 days from

    the date of closure of the subscription list.

    7. Despatch of Refund Orders

  • 7/31/2019 SEBI Guidelines for IPOs

    7/31

    Refund orders have to be dispatched within 30 days of the closure of the Public

    Issue.

    Refunds of excess application money i.e. for un-allotted shares have to be made

    within 30 days of the closure of the Public Issue.

    8. Other regulations pertaining to IPO

    Underwriting is not mandatory but 90% subscription is mandatory for each issue of

    capital to public unless it is disinvestment in which case it is not applicable.

    If the issue is undersubscribed then the collected amount should be returned back

    (not valid for disinvestment issues).

  • 7/31/2019 SEBI Guidelines for IPOs

    8/31

    If the issue size is more than Rs. 500 crores voluntary disclosures should be made

    regarding the deployment of the funds and an adequate monitoring mechanism to be

    put in place to ensure compliance.

    There should not be any outstanding warrants or financial instruments of any other

    nature, at the time of initial public offer.

    In the event of the initial public offer being at a premium, and if the rights under

    warrants or other instruments have been exercised within the twelve months prior

    to such offer, the resultant shares will not be taken into account for reckoning the

    minimum promoter's contribution and further, the same will also be subject to lock-

    in.

    Code of advertisement specified by SEBI should be adhered to.

    Draft prospectus submitted to SEBI should also be submitted simultaneously to all

    stock exchanges where it is proposed to be listed.

  • 7/31/2019 SEBI Guidelines for IPOs

    9/31

    9. Restrictions on other allotments

    Firm allotments to mutual funds, FIIs and employees not subject to any lock-in

    period.

    Within twelve months of the public/rights issue no bonus issue should be made.

    Maximum percentage of shares, which can be distributed to employees cannot be

    more than 5% and maximum shares to be allotted to each employee cannot be more

    than 200.

    10. Relaxations to public issues by infrastructure companies.

    These relaxations would be applicable to Infrastructure Companies as defined under

    Section 10(23G)

    of the Income Tax Act, 1961, provided their projects are appraised by any Developmental

    Financial

    Institution (DFI) or IDFC or IL&FS. The projects must also have a participation of at least

    5% of the

  • 7/31/2019 SEBI Guidelines for IPOs

    10/31

    project cost (in debt and/or equity) by the appraising institution.

    The infrastructure companies will be exempted from the requirement of making a

    minimum public offer of 25 per cent of its securities.

    The requirement of 5 shareholders per Rs. 1 lakh of offer is also waived in case of

    offerings by infrastructure companies.

    For public issues by infrastructure companies, minimum subscription of 90% would

    no longer be mandatory provided disclosure is made about the alternate source of

    funding which the company has considered, in the event of under subscription in the

    public issue.

    Infrastructure companies are permitted to freely price the offerings in the domestic

  • 7/31/2019 SEBI Guidelines for IPOs

    11/31

  • 7/31/2019 SEBI Guidelines for IPOs

    12/31

    has failed to repay debts to its creditor(s) in three consecutive quarters on demand made in writing for

    such repayment. The two basic factors which may

    result in sickness of an industrial unit are:-

    Internal factors are those which arise within an organisation. They include:-

    Mismanagement in various functional areas of a company like finance, production, marketing and

    personnel;

    Wrong location of a unit;

    Overestimation of demand and wrong dividend policy;

    Poor

  • 7/31/2019 SEBI Guidelines for IPOs

    13/31

    Poor inventory management in respect of finished goods as well as inputs;

    Unwarranted

    unproductive fixed assets,etc.;

    Failure

    environment;

    Poor

    External factors are those which take place outside an organisation. They include:-

    Energy

  • 7/31/2019 SEBI Guidelines for IPOs

    14/31

    Failure to achieve optimum capacity due to shortage of raw materials as a result of production set-backs

    in the supply industries,

    poor agricultural output because of natural reasons,changes in the import conditions,etc.

    Infrastructural problems like transport bottlenecks;

    Credit squeeze;

    Situations like market recession, changes in technology,etc;

    International

    Industrial sickness may be caused by a combination of all such factors. It has several adverse

    consequences on the economy as a whole. Some of which

    may be enumerated as follows:-

  • 7/31/2019 SEBI Guidelines for IPOs

    15/31

    It leads to loss of substantial revenue to the Government and enhances its public expenditure

    It locks up necessary resources and funds in the sick unit. This also increases the non-performing assets

    (NPAs) of banks and financial

    institutions;

    It leads to loss of production and productivity in the economy;

    It

    It vitiates the industrial atmosphere and leads to worker-management disputes,strikes,lock-outs,etc;

    It

    climate of the economy.

  • 7/31/2019 SEBI Guidelines for IPOs

    16/31

    In the light of the above consequences of sickness and its growing incidence by size, region and industry

    followed by its far-reaching adverse socio-

    economic

    has been the enactment of the Sick Industrial Companies (Special Provisions) Act,1985 (SICA).

    Sick Industrial Companies (Special Provisions) Act, 1985

    The most important piece of legislation dealing with industrial sickness was the Sick Industrial

    Companies (Special Provisions) Act,1985 (SICA). It

    applies to industrial undertakings both in the public and private sectors. SICA pertains to the industries

    specified in the First Schedule to the Industries

    (Development and Regulation) Act, 1951, (IDR Act) subject to the exceptions specified in the Act. SICA,

    including any rules or schemes made

    thereunder, had overriding provisions over other laws except the provisions of the Foreign Exchange

    Regulation Act,1973 and the Urban Land (Ceiling

    and Regulation) Act, 1976.

    The

    as to make the investments in such units profitable. At the same time, to ensure the closure of unviable

    units so as to release the investments locked up in

    such units for productive use elsewhere.

    Thus, the broad objectives of SICA were:-

    Timely detection of sick and potentially sick companies.

  • 7/31/2019 SEBI Guidelines for IPOs

    17/31

    Speedy

    such companies.

    The expeditious enforcement of the measures so determined and for all matters connected therewith or

    incidental thereto.

    The important provisions of SICA were:-

    It provided for the constitution of two quasi-judicial bodies, that is, Board for Industrial and Financial

    Reconstruction (BIFR) and

    Appellate

    was entrusted with the work of taking appropriate measures for revival and rehabilitation of potentially

    sick undertakings and for liquidation of

    non-viable companies. While, AAIFR was constituted for hearing the appeals against the orders of the

    BIFR.

    BIFR

    conditions:-

  • 7/31/2019 SEBI Guidelines for IPOs

    18/31

    If

    with respect to their company. Such reference was to be made within sixty days from the date of

    finalisation of the duly audited

    accounts of the company for the financial year at the end of which the company had become sick. For

    filing the reference, the

    Board

    On receiving such information (reference) with respect to a sick company or upon its own knowledge as

    to the financial condition

    of a company. Such a reference to the board may be made by:- (i) The Central Government; (ii) The

    Reserve Bank of India; (iii)

    State Governments; (iv) Public financial institutions; (v) State level institutions; or (vi) Scheduled banks.

    However,

    industrial undertakings (belonging to such a company) were situated in that State; (ii) a public financial

    institution or a State level institution

    or a scheduled bank, unless it had, by reason of any financial assistance or obligation rendered by it or

    undertaken by it, interest in such a

    company.

    The Board

  • 7/31/2019 SEBI Guidelines for IPOs

    19/31

    If the Board deems it fit to make an inquiry or to cause an inquiry to be made into any industrial

    company, it may appoint one or more persons

    as special director(s) of the company for safeguarding the financial and other interests of the company.

    The appointment of a special director

    shall be valid and effective notwithstanding anything to the contrary contained in the Companies Act,

    1956 or in any other law for the time

    being

    Any special director so appointed shall :- (i) hold office during the pleasure of the Board and may be

    removed or substituted by any person by

    order in writing by the Board; (ii) not incur any obligation or liability by reason only of his being a

    director or for anything done or omitted to

    be done in good faith in the discharge of his duties as a director or anything in relation thereto; (iii) not

    be liable to retirement by rotation and

    shall

    for anything, done or omitted to be done in good faith in the discharge of his duties in relation to the

    sick industrial company.

    If after making an inquiry, the Board is satisfied that the company has become sick, it shall, after

    considering all the relevant facts and

    circumstances

    If

  • 7/31/2019 SEBI Guidelines for IPOs

    20/31

    specified in the order, give such time to the company as it may deem fit to make its net worth exceed

    the accumulated losses.

    If the Board decides that it is not practicable for the sick company to make its net worth exceed the

    accumulated losses within a

    reasonable

    company, it may, as soon as may be, by order in writing, direct any operating agency specified in the

    order to prepare a scheme

    providing for such measures in relation to that company. The measures may include:-

    o

    o

    o

    o

    The financial reconstruction of the sick industrial company;

    The

    The amalgamation of the sick industrial company with any other company (transferee company), or any

    other company

    with the sick industrial company (transferee company);

  • 7/31/2019 SEBI Guidelines for IPOs

    21/31

    The

    o

    o

    Such other preventive, ameliorative and remedial measures as may be appropriate;

    Such

    the purposes of the measures specified above

    If the Board is of the opinion that the sick industrial company is not likely to make its net worth exceed

    the accumulated losses

    within a reasonable time while meeting all its financial obligations and that the company as a result

    thereof is not likely to become

    viable in future and that it is just and equitable that the company should be wound up, it may record

    and forward its opinion to

    the

    company in accordance with the provisions of the Companies Act, 1956.

    Where in respect of an industrial company, an inquiry is pending, or any scheme referred is under

    preparation or consideration or a sanctioned

  • 7/31/2019 SEBI Guidelines for IPOs

    22/31

    scheme is under implementation, then no proceedings for the winding-up of the industrial company or

    for execution, distress or the like

    against any of the properties of the industrial company shall be made. Also, no suit for the recovery of

    money or for the enforcement of any

    security

    proceeded with further, except with the consent of the Board or, as the case may be, the Appellate

    Authority.

    Also with respect to the above conditions, the Board may by order declare with respect to the sick

    industrial company concerned that the

    operation

    to which such sick industrial company is a party or which may be applicable to such sick industrial

    company immediately before the date of

    such order, shall remain suspended or that all or any of the rights, privileges, obligations and liabilities

    accruing or arising there under before

    the

    However, such declaration shall not be made for a period exceeding two years, which may be extended

    by one year at a time so that the total

    period shall not exceed seven years in the aggregate

    Under

    with

    mentioned

    officer

  • 7/31/2019 SEBI Guidelines for IPOs

    23/31

    CREDIT RATING AGENCIES

    ICRA Limited

    in 1991 by leading financial/investment institutions, commercial banks and financial services companies

    as

    Today,

    a

    Exchange.

    Alliance with Moodys Investors Service

    The international Credit Rating Agency Moodys Investors Service1 is ICRAs largest shareholder.

    The participation of Moodys is supported by a Technical Services Agreement, which entails Moodys

    providing certain high-value technical services to ICRA. Specifically, the agreement is aimed at

    benefiting ICRAs in-house research capabilities, and providing it with access to Moodys global research

    base.

    analysts on various subjects to help them better understand and manage concepts and issues relating to

    the development of the capital markets in India. Besides this formal training programme, the agreement

    provides for Moodys advising ICRA on Rating-products strategy, and the Ratings business in general.

    The ICRA Factor

    Facilitating Efficiency in Business...

    ICRA information products, Ratings, and solutions reflect independent, professional and impartial

  • 7/31/2019 SEBI Guidelines for IPOs

    24/31

    opinions, which assist businesses enhance the quality of their decisions and help issuers access a

    broader

    investor base and even lesser known companies approach the money and capital markets.

    The Research Factor...

    We

    capabilities. We have dedicated teams for Monetary, Fiscal, Industry and Sector research, and a panel

    of

    standards of quality and credibility.

    Committed to the Development of the Financial Market...

    The focus of ICRA in the coming years will continue to be on developing innovative concepts and

    products in a dynamic market environment, generating and promoting wider investor awareness and

    interest, enhancing efficiency and transparency in the financial market, and providing a healthier

    environment for market participants and regulators

    CRISIL

    Credit Rating and Information Services of India Ltd. (CRISIL) a global analytical company providing

    ratings, research, and risk and policy advisory services.

    CRISIL's majority shareholder is Standard and Poor's. Standard & Poor's, a part of The McGraw-Hill

    Companies, is the world's foremost provider of credit ratings.

  • 7/31/2019 SEBI Guidelines for IPOs

    25/31

    CRISIL is the largest credit rating agency in India. CRISIL pioneered ratings in India more than 20 years

    ago, and is today the undisputed business leader, with the

    largest number of rated entities and rating products: CRISIL's rating experience covers more than 41,738

    entities, including 20,000 small and medium enterprises

    (SMEs).

    CRISIL's Global Analytical Centre (GAC) supports the Global Resource Management initiative of Standard

    & Poor's (S&P). Under this initiative, GAC provides

    resources to S&P to improve workflow efficiencies, handle end-to-end analytical jobs, process

    information, and execute complex modelling assignments.

    CRISIL Research is India's largest independent research house. Through constant innovation, and

    comprehensive research offerings, covering the economy,

    industry and companies, CRISIL Research meets the requirements of more than 750 Indian and global

    clients. Apart from off-the-shelf research reports, CRISIL

    also provides incisive, customised research that allows clients to take informed business and investment

    decisions.

    CRISIL offers products and services covering both equity and debt markets thereby furthering CRISIL's

    objective to make markets function better.

    1. CRISIL Equities 2. Mutual Fund Research 3. Indices - IISL India Index Services and Products Ltd (IISL), a

    joint venture between NSE and CRISIL Ltd., was set

    up in May 1998 to provide a variety of indices and index related services and products for the Indian

    capital markets. It has a consulting and licensing agreement

    with Standard and Poor's (S&P), the world's leading provider of investible equity indices, for co-branding

    equity indices.

    CRISIL

  • 7/31/2019 SEBI Guidelines for IPOs

    26/31

    clients) with independent information, opinions and solutions related to credit ratings and risk

    assessment; energy, infrastructure and corporate advisory; research

    on India's economy, industries and companies; global equity research; fund services; and risk

    management.

    CRISIL Infrastructure Advisory* provides practical and innovative solutions to governments, donor

    funded agencies and leading organizations in over 20 emerging

    economies across the world to help improve infrastructure service delivery transform performance of

    public institutions and sector efficiency design and strengthen

    reform programs to catalyze private sector participation

    CRISIL is the largest credit rating agency in India. CRISIL pioneered ratings in India more than 20 years

    ago, and is today the undisputed business leader, with the largest

    number of rated entities and rating products: CRISIL's rating experience covers more than 45,676

    entities, including 23,500 small and medium enterprises (SMEs). As on

    September 30, 2011, we had more than 15,643 ratings (including over 8000 SMEs) outstanding.

    CRISIL Global Research & Analytics (GR&A) is the largest and top-ranked provider of high end research

    and analytics services to the world's leading commercial and

    investment banks, insurance companies, corporations, consulting firms, private equity players and asset

    management firms. CRISIL GR&A operates from research centers in

    Argentina, China, India and Poland, providing research support across several time zones and in multiple

    languages to global organizations.

    The CRISIL GR&A team has deep expertise in the areas of equity research, fixed income research

    (covering global economies, 150 global sectors and over 3000 global

    companies), valuations, pricing complex derivatives, structured finance, risk management, actuarial

    analysis and business intelligence. This expertise enables our clients

    enhance revenues, accelerate time to market, take pricing decisions and improve operational

    efficiencies.

  • 7/31/2019 SEBI Guidelines for IPOs

    27/31

    Being part of the CRISIL platform enables CRISIL GR&A to attract and retain top quality talent. CRISIL

    GR&A has over 2,000 employees, 75% of whom hold advanced degrees

    in finance, accounting and management. It has the largest teams of equity research analysts and

    derivative analysts outside of investment banks and the largest team of

    fixed income/credit analysts outside of banks/rating agencies.

    CRISIL GR&A has served more than 500 firms over the last decade. Our clients include:

    12 of the top 15 global investment banks

    2 of the top 10 global consulting groups

    3 of the top 10 global Asset Management Companies

    3 of the top 15 global insurance companies

  • 7/31/2019 SEBI Guidelines for IPOs

    28/31

    Several fortune 500 companies

    CRISIL Research is India's largest independent research house. Through constant innovation, and

    comprehensive research offerings covering economy, industry, companies

    CRISIL Research meets the requirements of more than 750 Indian and global clients. Apart from off the

    shelf research reports, CRISIL also provides incisive, customised

    research that allows clients to take informed business and investment decisions.

    Comprehensive research coverage on over 65 industries and 150 corporates makes CRISIL a preferred

    service provider to -

    90% of India's commercial banks

    4 of the world's largest consulting firms

    All the leading brokers, investment banks and private equity players

    CRISIL is an eminent player in the capital markets space with detailed perspective covering both debt

    and equity markets. CRISIL's capital market offerings can be

  • 7/31/2019 SEBI Guidelines for IPOs

    29/31

    categorised under equity research, initial public offer grading, mutual fund services, and fixed income

    services. Additionally, CRISIL provides customised research solutions

    as well.

    CRISIL Equities

    Offerings under CRISIL Equities are classified as - independent equity research (globally a unique

    concept) and initial public offer (IPO) grading. CRISIL equities also provide

    equity outsourcing and customised research for information memoranda and offer documents that are

    prepared by companies as part of their fund-raising initiatives.

    Mutual Fund Services

    CRISIL FundServices (CFS) is India's leading provider of rankings, desktop and valuation tools, indices and

    market benchmarks and customised investment research. Its Mutual

    Fund Rankings have been the industry standard for mutual fund evaluation in India for more than a

    decade.

    CFS has executed various policy level prestigious assignments -

    Assisted Employee Provident Fund Organisation (EPFO) in selection of fund managers to manage the

    EPFO's funds and provide better returns to its members.

    Assisted Provident Fund Regulatory and Development Authority (PFRDA) in framing regulations under

    the PFRDA act.

  • 7/31/2019 SEBI Guidelines for IPOs

    30/31

    RISIL Infrastructure Advisory* provides practical and innovative solutions to governments, donor funded

    agencies and leading organizations in over 20 emerging economies

    across the world to:

    Transform efficiency of public institutions and sector

    Design and strengthen reform programmes to catalyse private sector participation

    Improve infrastructure service delivery

    Some of the key assignments executed :

    CRISIL Infrastructure Advisory strategized the takeout finance scheme - a method of making long term

    debt financing available to large infrastructure projects

    for India Infrastructure Company Ltd (IIFCL).

  • 7/31/2019 SEBI Guidelines for IPOs

    31/31

    CRISIL Infrastructure Advisory's Energy Practice has designed and implemented first of its kind novel

    Electricity Distribution Franchisee Contract in

    Maharashtra.

    * Effective April 01, 2007, CRISIL transferred its advisory and risk consulting business into a wholly

    owned subsidiary, CRISIL Risk and Infrastructure Solutions Ltd (CRIS).

    CRISIL Risk Solutions* (CRS) provides comprehensive risk management services to banks, financial

    institutions, and corporates across all areas of risk including: credit,

    market and operational. In addition to providing innovative software products, it also extends

    consultancy services and analytical insights, which are focused on helping

    customers become Basel II-compliant.

    Ranked as the No. 1 Risk Solution provider in the last Indian Banks' Association (IBA) Finsight media

    survey, CRISIL Risk Solutions has delivered risk solutions to about 50

    financial institutions in India and abroad and has largest user base of more than 100000 users. CRS's

    flagship product RAM is the largest deployed Internal risk rating solution

    in India.

    * Effective April 1, 2007, CRISIL transferred its advisory and risk consulting business into a wholly owned

    subsidiary, CRISIL Risk and Infrastructure Solutions Ltd (CRIS).